Autoradiographic visualization of beta-adrenoceptor subtypes in human lung.
about
Bench-to-bedside review: the role of the alveolar epithelium in the resolution of pulmonary edema in acute lung injury.The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder diseaseUse of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmaticsPharmacological actions of the selective and non-selective beta-adrenoceptor antagonists celiprolol, bisoprolol and propranolol on human bronchiParticle transport and deposition: basic physics of particle kineticsβ-Adrenergic agonists differentially regulate highly selective and nonselective epithelial sodium channels to promote alveolar fluid clearance in vivo.Bronchodilator aerosol administered by metered dose inhaler and spacer in subacute neonatal respiratory distress syndrome.Human lung and monocyte-derived macrophages differ with regard to the effects of β2-adrenoceptor agonists on cytokine releaseStimulation of lung epithelial liquid clearance by endogenous release of catecholamines in septic shock in anesthetized rats.Methods to identify drug deposition in the lungs following inhalationA comparison of the effect of salmeterol and salbutamol in normal subjects.Direct relationship between mononuclear leukocyte and lung beta-adrenergic receptors and apparent reciprocal regulation of extravascular, but not intravascular, alpha- and beta-adrenergic receptors by the sympathochromaffin system in humans.Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheepNasal potential difference to detect Na+ channel dysfunction in acute lung injury.Postnatal changes in beta-adrenoceptors in the lung and the effect of hypoxia induced pulmonary hypertension of the newborn.Quantification of beta adrenergic receptor subtypes in beta-arrestin knockout mouse airways.Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo.Polymorphism profiling of nine high altitude relevant candidate gene loci in acclimatized sojourners and adapted natives.The long-acting β2 -adrenoceptor agonist olodaterol attenuates pulmonary inflammation.Distribution of beta 1- and beta 2-adrenoceptors in mouse trachea and lung: a quantitative autoradiographic study.Albuterol modulates its own transepithelial flux via changes in paracellular permeability.Regional quantification of muscarinic acetylcholine receptors and β-adrenoceptors in human airways.Respiratory syncytial virus induces insensitivity to beta-adrenergic agonists in mouse lung epithelium in vivoMolecular biology and respiratory disease. 5. Molecular biology of receptors: implications for lung disease.Novel role for CFTR in fluid absorption from the distal airspaces of the lungSalmeterol restores secretory functions in cystic fibrosis airway submucosal gland serous cells.An environmental epigenetic study of ADRB2 5'-UTR methylation and childhood asthma severity.Alveolar epithelial beta2-adrenergic receptors.Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary diseaseAlbuterol Improves Alveolar-Capillary Membrane Conductance in Healthy Humans.Acute bacterial pneumonia in rats increases alveolar epithelial fluid clearance by a tumor necrosis factor-alpha-dependent mechanism.In vitro considerations to support bioequivalence of locally acting drugs in dry powder inhalers for lung diseases.The case for impulse oscillometry in the management of asthma in children and adults.Beta-Adrenergic AgonistsEpithelium derived relaxing factor: myth or reality?Beta adrenoceptor binding and induced relaxation in airway smooth muscle from patients with chronic airflow obstruction.Delivery of propellant soluble drug from a metered dose inhalerComparison of the effects of salbutamol and adrenaline on airway smooth muscle contractility in vitro and on bronchial reactivity in vivo.Comparison of the effects of selective inhibitors of phosphodiesterase types III and IV in airway smooth muscle with differing beta-adrenoceptor subtypes.
P2860
Q24800694-58829A68-1C31-4936-8641-A47E67315E1DQ26864937-E2C4AAB9-AE9F-4DDA-98DB-A0AFBC1D1699Q28066822-8B0D5E48-E671-48AA-8412-57E1773D7CB0Q28307382-82978A8D-C61E-4E70-8A24-A5207E3CD6C9Q28391883-160CB8CF-8717-41BE-8382-310A159AF0EDQ29347099-2390806E-03A3-44A9-8FA7-6B7B6622ED7CQ33706405-DC8EC43A-68D5-43C8-9B1F-AE0C197BFD0DQ33823753-02F8CD27-A620-4B96-B573-116D8F42E82FQ34229083-F734889C-B3AE-418A-9049-0D7097B94F09Q34229278-C8AAF230-393E-41A0-988B-B34C7E3AF776Q34402874-835BBA98-0356-487D-9676-89B07B9CFE1DQ34556465-F4168D8D-4D3B-431B-8F34-222E1F686E7BQ34557584-7DAA65D4-4E1E-4B31-A3A5-D47C1566AE52Q34720193-90D93ED8-063F-4D23-997C-896A24251182Q35044221-8E85CD83-0CD3-48E2-9FBA-EA23FF2A7970Q35057786-C13886E6-2D55-4D86-96E5-B21CC24E9A6BQ35583182-B6BB5192-C436-410B-99D1-F8776EDF9839Q35749992-769C4C03-E8A0-45E5-86F2-F8E4D0507A46Q35776631-38EDEFBA-3A66-4B0D-9BAC-6FD61DA32FE5Q35865433-9D7B39BE-90E5-4E8D-8330-B14E5894BF3BQ35888015-9C320B8C-E806-4633-8FC3-E4B7C61EC781Q35987306-3A4D5124-5A76-4930-966F-DD72950B430EQ36110580-2BD3F7AC-24C5-4652-A5F3-DB2D16A75F3EQ36157363-AEEEC4CE-CC02-46AC-A8D7-354E0EAEAFDFQ36222495-8D77036C-0B15-45D3-B943-144049743601Q36445092-4725F58B-E4DC-495E-B92F-8CD74E2047FAQ36568698-B0B732FC-3FC1-44B5-AB4C-AD5065852E78Q36905423-EBCF90AD-BBD0-4569-98F7-7C6B44FD45EEQ36914692-9ED567D6-72E0-495F-834A-269A5EB370BEQ37047304-AAB64276-A731-47C6-AFD6-E84C72D76CE6Q37338441-C5E2B44A-1A8F-4F64-A88A-8327104C17FEQ37362616-94128130-B953-467A-931C-3F1054181421Q37507766-0A60356A-3B0D-4528-B659-4FE52B5CA1FBQ38742722-CDD9CEE0-CE3F-46EF-B727-90C98D493A9FQ38974241-54117E33-BB5D-43AA-A54C-B04B1D653BAFQ39543425-F9276AF6-0882-458F-88B7-D622E0201756Q41133398-5E0AA535-9C4C-496B-B874-52FB4EE7817DQ41142155-0739BE9D-B020-47E7-AE62-A2E6E6D8CC99Q41235059-D06B0935-3176-43C6-9190-9F538D7D2971Q42129903-244EA245-40A6-4C1D-A695-99C640F6BE3F
P2860
Autoradiographic visualization of beta-adrenoceptor subtypes in human lung.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Autoradiographic visualization of beta-adrenoceptor subtypes in human lung.
@ast
Autoradiographic visualization of beta-adrenoceptor subtypes in human lung.
@en
type
label
Autoradiographic visualization of beta-adrenoceptor subtypes in human lung.
@ast
Autoradiographic visualization of beta-adrenoceptor subtypes in human lung.
@en
prefLabel
Autoradiographic visualization of beta-adrenoceptor subtypes in human lung.
@ast
Autoradiographic visualization of beta-adrenoceptor subtypes in human lung.
@en
P2093
P1476
Autoradiographic visualization of beta-adrenoceptor subtypes in human lung.
@en
P2093
P304
P356
10.1164/ARRD.1985.132.3.541
P577
1985-09-01T00:00:00Z